# Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in Jordan

> **NCT03517982** · — · COMPLETED · sponsor: **Hikma Pharmaceuticals LLC** · enrollment: 12 (actual)

## Conditions studied

- Acute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant

## Interventions

- **DRUG:** Mycophenolate Mofetil

## Key facts

- **NCT ID:** NCT03517982
- **Lead sponsor:** Hikma Pharmaceuticals LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03517982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03517982, "Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in Jordan". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03517982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*